Search results
Baird lifts Mirum Pharmaceuticals shares target on study results By Investing.com
Investing.com· 7 days agoOn Monday, Baird increased its price target on Mirum Pharmaceuticals (NASDAQ:MIRM) shares to $39...
3D printing of drugs can revolutionise personalised medicine and improve sustainability
Medical Device Network via Yahoo Finance· 6 days ago3D Printing Drugs: Advancing Personalized Medicine and Sustainability As the pharmaceutical industry...
Pharma giant's data breach exposes patients' sensitive information
Fox News via Yahoo News· 7 days agoPharmaceutical giant Cencora has notified people that private medical information, including health...
Arcturus Therapeutics appoints Moncef Slaoui to board By Investing.com
Investing.com· 4 days ago(NASDAQ:ARCT), a biotechnology company specializing in mRNA medicines for infectious diseases and...
As big pharma exits Nigeria, asthma patients face spiralling costs
Al Jazeera· 5 days agoThe following week, when she went out in Ibadan city to replace her old Ventolin inhaler, the asthma...
Aspirin Use Enhances Immunosurveillance in Colorectal Cancer
Medscape· 3 days agoProf David Kerr discusses recent study results related to the impact of aspirin on the tumor...
Gateway - Quartz
Quartz· 5 days agoCEO Anne Wojcicki is on a crisis tour, promising investors the company isn’t going out of business because she has a new plan: 23andMe is going to double down on mining your DNA data and selling ...
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 5 days agoReal-world study data suggest there is little difference among five drug classes commonly used to...
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 5 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...
New JAK 1 Inhibitor Proves Promising in Phase 3 RA Trial
Medscape· 5 days agoThe highly selective oral Janus kinase (JAK) inhibitor SHR0302 (ivarmacitinib) enables more patients...